Skip to main content
Caplight Logo









ApoWiser

ApoWiser

Private
Ra'ananaHealthcare & Life Scienceshttps://apowiser.com

Last Round

Seed

Jun 21, 2022

Total Funding Raised

$1.5M

Company Overview

ApoWiser operates in Healthcare & Life Sciences and is based in Ra'anana. Its latest recorded funding round was a Seed round in June 2022.

ApoWiser is a health tech company that provides an AI-powered digital pharmacist platform for personalized over-the-counter medication and supplement guidance.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Patient Engagement, Retail Technology

Business Model

B2B2C

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ApoWiser Comparables

Compare ApoWiser with similar companies based on industry and business-model similarity.

ApoWiser comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wrapped Health
62%
Healthily
61%
Medisafe
55%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ApoWiser Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 21, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Alon Sudri

CTO and Co-Founder

Founding Team

For institutional investors. Book with your work email.

ApoWiser Investors

Notable investors and investment history

ApoWiser investors
InvestorRounds
Longliv VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors grew 2362% MoM, from 13 to 320.

  • Jun 21, 2022

    $1.5M round led by Longliv Ventures

Book a demo to see all signals

For institutional investors. Book with your work email.

ApoWiser Filings

Explore SEC and related filing metadata, where available.

ApoWiser filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ApoWiser's valuation, stock price, and market status.

Is ApoWiser a public or private company?

ApoWiser is a private company.

What is the current stock price of ApoWiser?

ApoWiser is a private company, so its shares have no public market price. Caplight tracks ApoWiser's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ApoWiser worth (valuation)?

Valuation information for ApoWiser is not publicly available.

Can I buy ApoWiser stock?

ApoWiser shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ApoWiser's last funding round?

ApoWiser's most recent funding round was Seed on June 21, 2022.

Who are the main investors in ApoWiser?

Key investors in ApoWiser include Longliv Ventures.

Will ApoWiser IPO soon?

No public IPO plans have been announced for ApoWiser.

How can I track ApoWiser secondary market activity?

Caplight tracks bids, offers, and trades in ApoWiser's shares on secondary markets.

Firmographic Details

HeadquartersRa'anana
Employee Range2
Year Founded2021
Last FundingJun 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?